Fourth annual consortium meeting in NYC with the inaugural Biomarker Summit
Over 3000 participants are enrolled in PRECEDE
Third annual consortium meeting in NYC
PRECEDE Consortium Announces Konica Minolta Precision Medicine as its Precision Health Partner to Advance its Mission to Increase Survival Rates for Patients with Pancreatic Cancer
Greater than 1000 participants enrolled in PRECEDE
Second Annual PRECEDE Consortium Meeting, virtual
First participant enrolled in PRECEDE, at NYU
PRECEDE study protocol approved by sIRB
First Annual PRECEDE Consortium Meeting in NYC
Pancreatic Cancer Early Detection Research Consortium (PRECEDE) name is adopted
Project Purple and IMPACT PDA International Consortium execute contract with Arbor Research for build of electronic data collection platform, biosample labeling and tracking, and site onboarding for the first 25 clinical sites
Project Purple and NYU announce $1.25 million dollar gift to support early detection research
First “Early Detection Collaboration Meeting”